medigraphic.com
ISSN 2007-087X (Print)
Órgano Oficial de la Sociedad Mexicana de Ortopedia Pediátrica

2023, Number 1-3

<< Back Next >>

Rev Mex Ortop Ped 2023; 25 (1-3)

Malawer type VI B resection and lung metastatectomy in adolescent patient due to a giant cell tumor of the proximal humerus

Sánchez-Torres LJ, Dávila HEI

Language: Spanish
References: 22
Page: 39-43
PDF size: 185.50 Kb.


ABSTRACT

Introduction: the giant cell tumor of bone is a rare entity before the third decade of life, as well as the development of lung metastasis. Aggressive and large lesions make treatment difficult. Case presentation: it is the case of a 17-year-old female with a giant cell tumor of bone in the right proximal humerus showing cortical destruction and joint and scapular invasion, and also soft tissue involvement. The patient was treated with a Malawer type VI B resection that progressed without complications; a good function was obtained in the elbow and excellent in the wrist and hand. The patient developed a single lung metastasis treated with metastatectomy by minithoracotomy, confirming diagnosis. Conclusions: giant cell tumor of bone is a diagnostic and therapeutic challenge, especially when it presents before its usual age. The treatment alternative depends on the location and size of the lesion. Lung metastasis although rare, must be continuously ruled out. Early diagnosis and timely treatment have a positive impact on the patient.


REFERENCES

  1. Campanacci M. Giant cell tumor (giant cell tumor of bone, osteoclastoma). In: Campanacci M. Bone and soft tissue tumors: clinical features, imaging, pathology and treatment. 2nd edition. New York: Springer-Verlag; 1999. pp. 99-142.

  2. Zhang XP, Lu XC, Wang LL, Wei JQ, Yan J, Shao XN et al. Giant cell tumors of bone in patients aged 18 years old or younger: imaging features and tumor characteristics. Int J Gen Med. 2021; 14: 8389-8397. doi: 10.2147/IJGM.S330507.

  3. Sobti A, Agrawal P, Agarwala S, Agarwal M. Giant cell tumor of bone - an overview. Arch Bone Jt Surg. 2016; 4(1): 2-9.

  4. Flanagan AM, Larousserie F, O'Donnell PG, Yoshida A. Giant cell tumour of bone. In: WHO Classification of tumours, soft tissue and bone tumours. Vol. 3. 5th edition. Lyon, France: International Agency for Research on Cancer; 2020. pp. 440-446.

  5. Sánchez-Torres LJ, Flores FA, Santos HM. Tumor óseo de células gigantes en pacientes de menos de 20 años de edad. Rev Mex Ortop Ped. 2012; 1: 26-30.

  6. Nielsen GP, Rosenberg AE. Giant cell – rich tumors. In: Diagnostic pathology bone. 3rd edition. Philadelphia: Elsevier; 2021. pp. 307-333.

  7. Hartmann W, Harder D, Baumhoer D. Giant cell-rich tumors of bone. Surg Pathol Clin. 2021; 14(4): 695-706.

  8. van der Heijden L, Dijkstra S, van de Sande M, Gelderblom H. Current concepts in the treatment of giant cell tumour of bone. Curr Opin Oncol. 2020; 32: 332-338.

  9. Enneking WF. A system of staging musculoskeletal neoplasms. Clin Orthop Relat Res. 1986; 204: 9-24.

  10. Campanacci M, Baldini N, Boriani S, Sudanese A. Giant cell tumor of bone. J Bone Joint Surg Am. 1987; 69(1): 106-114. doi: 10.2106/00004623-198769010-00018.

  11. Estrada-Villaseñor EG, Hidalgo BA, Bandala C, De la Garza-Montano P, Reyes MN, Pichardo BR et al. Correlation between Campanacci's radiological classification of giant cell tumor of bone and expression of cyclin D1 and PCNA. JST. 2017; 7(1): 47-51.

  12. Malawer MM. Tumors of the shoulder girdle. Technique of resection and description of a surgical classification. Orthop Clin North Am. 1991; 22(1): 7-35. Available in: https://www.ncbi.nlm.nih.gov/pubmed/1992436

  13. Oztürk R, Arikan SM, Togral G, Güngor BS. Malignant tumors of the shoulder girdle: surgical and functional outcomes. J Orthop Surg (Hong Kong). 2019; 27(2): 2309499019838355. doi: 10.1177/2309499019838355.

  14. Enneking WF. Modification of the system for functional evaluation in the surgical management of musculoskeletal tumors. In: Enneking WF, editor. Limb salvage in musculoskeletal oncology. New York: Churchill Livingstone; 1987. pp. 626-639.

  15. Enneking WF, Dunham W, Gebhardy MC, Malawer M, Pritchard DJ. A system for the functional evaluation of reconstructive procedures after surgical treatment of tumors of the musculoskeletal system. Clin Orthop Relat Res. 1993; 286: 241-246.

  16. Puri A, Agarwal M, Shah M, Jambhekar NA, Anchan C, Bhele S. Giant cell tumor of bone in children and adolescents. J Pediatr Orthop. 2007; 27: 635-639.

  17. Arbeláez EP, Manrique SJ, Linares RFB. Tumor de células gigantes óseo en niños y adolescentes: reporte de 11 casos. Rev Colomb Ortop Traumatol. 2017; 31(4): 172-177.

  18. Cortés-Rodríguez R, Lezama-Del Valle P, Mendoza-Delgado FJ, Ortega-López A, Rubio-Arenas A, González-Assad V et al. Tumor de células gigantes. Hemipelvectomía interna izquierda en una niña de nueve años. Reporte de caso. Arch Inv Mat Inf. 2018; 9(2): 76-80.

  19. Bracamontes-Barahona R, Calderón-Sauri I, Chan-Jiménez J, Flores-Mendoza K, Alejos-Gómez R, Méndez-Domínguez N. Tumor de células gigantes de localización isquiopúbica en paciente pediátrico: reporte de caso clínico. Rev Mex Ortop Ped. 2018; 2: 93-97.

  20. Reynoso-Soto L, Cervantes Gudiño JE. Tumor de células gigantes en un paciente pediátrico. Reporte de un caso y revisión de la literatura. Lux Médica. 2020; 15(45): 55-61.

  21. Chan CM, Adler Z, Reith JD, Gibbs CP Jr. Risk factors for pulmonary metastases from giant cell tumor of bone. J Bone Joint Surg Am. 2015; 97(5): 420-428.

  22. Chawla S, Henshaw R, Seeger L, Choy E, Blay JY, Ferrari S et al. Safety and efficacy of denosumab for adults and skeletally mature adolescents with giant cell tumour of bone: interim analysis of an open-label, parallel – group, phase 2 study. Lancet Oncol. 2013; 14(9): 901-908.



EVIDENCE LEVEL

IV




2020     |     www.medigraphic.com